NEW YORK − Kinnate Biopharma said on Wednesday that it has raised $98 million in a Series C financing round led by RA Capital Management.
To read the full story....
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.